- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Automatic Translation feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
A survey of patients that had a prescription of an adrenalin auto-injector in our department
-
- Yasui Masahiro
- Department of Allergy, Aichi Children's Health and Medical Center
-
- Hino Asuka
- Department of Allergy, Aichi Children's Health and Medical Center
-
- Maeda Toru
- Department of Allergy, Aichi Children's Health and Medical Center
-
- Kobayashi Takae
- Department of Allergy, Aichi Children's Health and Medical Center
-
- Haneda Yasuhiro
- Department of Allergy, Aichi Children's Health and Medical Center
-
- Kando Naoyuki
- Department of Allergy, Aichi Children's Health and Medical Center
-
- Ito Komei
- Department of Allergy, Aichi Children's Health and Medical Center
Bibliographic Information
- Other Title
-
- 当科でアドレナリン自己注射器を処方した患者の実態調査
Search this article
Description
Intramuscular adrenalin injection is the first line treatment for anaphylactic shock, and an adrenalin auto-injector (Epipen®) is commercially available in Japan. A total of 211 prescriptions were given to 117 patients from August 2005 to February 2011. The patients' age at thetime of their first prescription ranged from 2.5 to 27.8 years (median: 7.0 years). The dominant offending allergens were hen's eggs (n=56) and cow's milk (n=55). Six patients (5.1%) used the injector, four of them used it as a pre-hospital care and the others used it in the hospital. One accidental shot was reported when the injector was dropped on the floor at school. A questionnaire to the parents and the patients, who were 12 years of age or more, revealed that almost half of the patients and parents did not feel confident in their judgment of when to use Epipen®. Few patients repeatedly practiced the use of this injector at home, and nearly half of all parents did not understand whether or not there was an emergency plan including the administration of Epipen® in schools. In conclusion, precise instructions at the time of prescription, and repeated education should be emphasized for all patients that had a prescription of an Epipen®.<br>
Journal
-
- Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology
-
Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology 27 (5), 684-691, 2013
THE JAPANESE SOCIETY OF PEDIATRIC ALLERGY AND CLINICAL IMMUNOLOGY
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679451678208
-
- NII Article ID
- 130004504352
-
- ISSN
- 18822738
- 09142649
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed
